182 related articles for article (PubMed ID: 27578457)
1. Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice.
Tomas-Roig J; Benito E; Agis-Balboa RC; Piscitelli F; Hoyer-Fender S; Di Marzo V; Havemann-Reinecke U
Addict Biol; 2017 Nov; 22(6):1778-1789. PubMed ID: 27578457
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia.
Gleason KA; Birnbaum SG; Shukla A; Ghose S
Transl Psychiatry; 2012 Nov; 2(11):e199. PubMed ID: 23188199
[TBL] [Abstract][Full Text] [Related]
3. Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice.
Aguilar MA; Ledesma JC; Rodríguez-Arias M; Penalva C; Manzanedo C; Miñarro J; Arenas MC
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635664
[TBL] [Abstract][Full Text] [Related]
4. Comparing dopaminergic dynamics in the dorsolateral striatum between adolescent and adult rats: Effect of an acute dose of WIN55212-2.
Pérez-Valenzuela E; Castillo-Faúndez R; Fuentealba JA
Brain Res; 2019 Sep; 1719():235-242. PubMed ID: 31181184
[TBL] [Abstract][Full Text] [Related]
5. Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment.
Wegener N; Koch M
Brain Res; 2009 Feb; 1253():81-91. PubMed ID: 19094973
[TBL] [Abstract][Full Text] [Related]
6. Increased BDNF-TrkB signaling in the nucleus accumbens plays a role in the risk for psychosis after cannabis exposure during adolescence.
Dong C; Tian Z; Zhang K; Chang L; Qu Y; Pu Y; Ren Q; Fujita Y; Ohgi Y; Futamura T; Hashimoto K
Pharmacol Biochem Behav; 2019 Feb; 177():61-68. PubMed ID: 30629965
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of chronic WIN 55,212-2 administration during adolescence and adulthood in mice.
Johnson KR; Boomhower SR; Newland MC
Exp Clin Psychopharmacol; 2019 Aug; 27(4):348-358. PubMed ID: 31120283
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine.
Scherma M; Qvist JS; Asok A; Huang SC; Masia P; Deidda M; Wei YB; Soni RK; Fratta W; Fadda P; Kandel ER; Kandel DB; Melas PA
Proc Natl Acad Sci U S A; 2020 May; 117(18):9991-10002. PubMed ID: 32312805
[TBL] [Abstract][Full Text] [Related]
10. Gene expression signature in brain regions exposed to long-term psychosocial stress following acute challenge with cannabinoid drugs.
Tomas-Roig J; Havemann-Reinecke U
Psychoneuroendocrinology; 2019 Apr; 102():1-8. PubMed ID: 30476795
[TBL] [Abstract][Full Text] [Related]
11. Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapine.
Leweke FM; Schneider M
Int J Neuropsychopharmacol; 2011 Feb; 14(1):43-51. PubMed ID: 20678304
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic cannabinoid exposure during adolescence on reward preference and mPFC activation in adulthood.
Jacobs-Brichford E; Manson KF; Roitman JD
Physiol Behav; 2019 Feb; 199():395-404. PubMed ID: 30529340
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats.
Schneider M; Schömig E; Leweke FM
Addict Biol; 2008 Sep; 13(3-4):345-57. PubMed ID: 18782382
[TBL] [Abstract][Full Text] [Related]
14. Adolescent cannabinoid exposure effects on natural reward seeking and learning in rats.
Schoch H; Huerta MY; Ruiz CM; Farrell MR; Jung KM; Huang JJ; Campbell RR; Piomelli D; Mahler SV
Psychopharmacology (Berl); 2018 Jan; 235(1):121-134. PubMed ID: 29022083
[TBL] [Abstract][Full Text] [Related]
15. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2.
Schneider M; Drews E; Koch M
Behav Pharmacol; 2005 Sep; 16(5-6):447-54. PubMed ID: 16148450
[TBL] [Abstract][Full Text] [Related]
16. Behavioral sensitization to heroin by cannabinoid pretreatment in the rat.
Pontieri FE; Monnazzi P; Scontrini A; Buttarelli FR; Patacchioli FR
Eur J Pharmacol; 2001 Jun; 421(3):R1-3. PubMed ID: 11516439
[TBL] [Abstract][Full Text] [Related]
17. Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice.
Naderi N; Haghparast A; Saber-Tehrani A; Rezaii N; Alizadeh AM; Khani A; Motamedi F
Pharmacol Biochem Behav; 2008 Mar; 89(1):64-75. PubMed ID: 18096213
[TBL] [Abstract][Full Text] [Related]
18. Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice.
Brzózka MM; Fischer A; Falkai P; Havemann-Reinecke U
Behav Brain Res; 2011 Apr; 218(2):280-7. PubMed ID: 21070814
[TBL] [Abstract][Full Text] [Related]
19. Chronic exposure to a synthetic cannabinoid alters cerebral brain metabolism and causes long-lasting behavioral deficits in adult mice.
Bouter C; Ott FW; Günther D; Weig L; Schmitz-Peiffer F; Rozyyeva M; Beindorff N; Bouter Y
J Neural Transm (Vienna); 2023 Aug; 130(8):1013-1027. PubMed ID: 36853560
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats.
Pamplona FA; Bitencourt RM; Takahashi RN
Neurobiol Learn Mem; 2008 Jul; 90(1):290-3. PubMed ID: 18486502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
